Skip to content
Homepage
Author:
Vivos Therapeutics, Inc
Posted Date:
August 14, 2026
Vivos Therapeutics Reports Second Quarter 2026 Financial Results and Provides Operational Update
Vivos Therapeutics, Inc
August 14, 2026
Vivos Therapeutics Schedules Release of Second Quarter 2026 Financial Results and Conference Call
Vivos Therapeutics, Inc
August 14, 2026
Vivos Therapeutics Expands Greenway Health Partnership to Deploy AI-Enabled Platform Across All Clinical and Revenue Operations
Vivos Therapeutics, Inc
August 11, 2026
Vivos Therapeutics Announces Issuance of New US Patent Broadening Protection for Its Vivos CARE Oral Medical Device Technology
Vivos Therapeutics, Inc
August 5, 2026
Vivos’ Vida® Appliance Shows Statistically Significant Improvement in Insomnia Severity in 100% of Study Participants
Vivos Therapeutics, Inc
June 30, 2026
Vivos Therapeutics and Streeterville Extend Timeframe of Strategic Financing Agreement and Reaffirm Commitment to Convert Debt Into Common Stock and Perpetual Preferred Equity
Vivos Therapeutics, Inc
June 22, 2026
